sales@fnfresearch.comTel: +86 21 80360450 | USA: +1-347-989-3985

Search Market Research Report

Home / Healthcare / Antibody Drug Conjugates

Antibody Drug Conjugates Market by Drugs (Adcetris and Kadcyla), Mechanism of Action (CD30 Antibodies and HER2 Antibodies), Application (Breast Cancer, Lymphoma, and Other Types of Cancer): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2026

  • Publish On: Aug-2020
  • Total Pages: 190
  • Report Code: FAF-1264
  • Base Year: 2019
  • Format:

Industry Insights

This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the  Antibody Drug Conjugates industry. The report analyzes and declares the historical and current trends analysis of the  Antibody Drug Conjugates industry and subsequently recommends the projected trends anticipated to be observed in the  Antibody Drug Conjugates market during the upcoming years.

The  Antibody Drug Conjugates market report analyzes and notifies the industry statistics at the global as well as regional and country levels to acquire a thorough perspective of the entire  Antibody Drug Conjugates market. The historical and past insights are provided for FY 2016 to FY 2019 whereas projected trends are delivered for FY 2020 to FY 2026. The quantitative and numerical data is represented in terms of value (USD 4,670 Million) from FY 2016 – 2026.

The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the  Antibody Drug Conjugates industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.

Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the  Antibody Drug Conjugates industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the  Antibody Drug Conjugates market.

The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders involved in the entire value chain of the  Antibody Drug Conjugates industry. The  Antibody Drug Conjugates market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.

The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the  Antibody Drug Conjugates sector. Key strategic developments in the  Antibody Drug Conjugates market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the  Antibody Drug Conjugates market are appropriately highlighted in the report.

The worldwide market for ADC is expected to be driven by the advancement of clinical innovation. The key drivers of the market are the increasing prevalence of cancer, the development of mature populations, and the increase in large populations. Besides, the expanding research exercises on immune response treatments, preclinical examination, more exploration on cutting edge tranquilize revelations and expanding research on oncology infections and the developing joint effort between research foundations, Biotechnology, and Biopharmaceuticals organizations is likewise going about as a fuel to the market and is relied upon to drive the market of ADC inside the estimate time frame. However, the significant expense of the methodology and the lack of funds can be the restriction for the development of this market.

The Antibody Drug Conjugates industry has been segmented on the basis of drugs, application, mechanism of action, and region. The drugs segment is divided into adcetris and kadcyla. Further, the mechanism of action segment is classified as HER2 antibodies and CD30 antibodies. Additionally, the application segment is classified as lymphoma, breast cancer, and others.

The major players operating in the market are Synthon Holding B.V., Seattle Genetics Inc., Sanofi S.A., Progenics Pharmaceuticals Inc., Pfizer, Inc., Immunomedics, Inc., Immunogen Inc., Genentech Inc., Celldex Therapeutics Inc., and Bayer Healthcare Pharmaceuticals among others. Major operating players in the Antibody Drug Conjugates market concentrate on manufacturing more advanced, reliable, and cost-effective masks to lead to the growth of revenues in the industry.

The taxonomy of the  Antibody Drug Conjugates Market by its scope and segmentation is as follows:

Global Antibody Drug Conjugates Market: Drugs Segment Analysis

  • Adcetris
  • Kadcyla

Global Antibody Drug Conjugates Market: Mechanism of Action Segment Analysis

  • CD30 Antibodies
  • HER2 Antibodies

 Global Antibody Drug Conjugates Market: Application Segment Analysis

  • Breast Cancer
  • Lymphoma

Global  Antibody Drug Conjugates Market: Regional Segment Analysis

 

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • The UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

KEY REPORT POINTERS & HIGHLIGHTS:

  • Statistically Validated Analysis of Historical, Current, and Projected Industry Trends with Authenticated Market Sizes Information and Data in terms of Value and Volume, wherever applicable
  • Direct and Indirect Factors that Impacted the Industry as well Projected Rationales expected to affect the industry going forward
  • Micro, Meso, Macro, and In-Depth Analysis of Technically relevant and Commercially viable Segments and Sub-segments of the Market
  • Historical and Projected Company / Vendor / OEM / Supplier Market Shares, Competitive Landscape, and Player Positioning Data
  • Historical and Current Demand (Consumption) and Supply (Production) Scenarios as well as Projected Supply-Demand Scenario Analysis
  • Detailed List of Key Buyers and End-Users (Consumers) analyzed as per Regions and Applications
  • Value Chain and Supply Chain Analysis along with Horizontal and Vertical Integration Scenarios
  • Manufacturing and Production Cost Structure Analysis including Labor Cost, Raw Material Expenses, and Other Manufacturing Expenses, wherever relevant
  • Overview of Key Marketing Strategies and Key Sales Channels Adopted in the Market
  • Market Attractiveness Analysis and Key Investment Opportunity Analysis in the Market going forward
  • Technological Roadmap, Patents Analysis, Potential Substitutes, and Technical Analysis
  • The professionally substantiated market research report study is calculated, constructed, and assembled by implementing a robust research methodology. The triangular process comprises a buoyant mix of exhaustive primary research (focused interviews, questionnaires, and ad-hoc surveys) and extended secondary research (paid external databases, proprietary in-house database, and publically-available validated sources), where it is finally triangulated and validated through in-house industry experts, industry leaders, and independent consultants through a tri-level quality check practice

Table of Content

  1. CHAPTER 1. Executive Summary
  2. CHAPTER 2. Antibody Drug Conjugates market – Drugs Analysis
    1. 2.1. Global Antibody Drug Conjugates Market – Drugs Overview
    2. 2.2. Global Antibody Drug Conjugates Market Share, by Drugs, 2018 & 2025 (USD Million)
    3. 2.3. Adcetris
      1. 2.3.1. Global Adcetris Antibody Drug Conjugates Market, 2015-2025 (USD Million)
    4. 2.4. Kadcyla
      1. 2.4.1. Global Kadcyla Antibody Drug Conjugates Market, 2015-2025 (USD Million)
  3. CHAPTER 3. Antibody Drug Conjugates market – Mechanism of Action Analysis
    1. 3.1. Global Antibody Drug Conjugates Market – Mechanism of Action Overview
    2. 3.2. Global Antibody Drug Conjugates Market Share, by Mechanism of Action, 2018 & 2025 (USD Million)
    3. 3.3. CD30 Antibodies
      1. 3.3.1. Global CD30 Antibodies Antibody Drug Conjugates Market, 2015-2025 (USD Million)
    4. 3.4. HER2 Antibodies
      1. 3.4.1. Global HER2 Antibodies Antibody Drug Conjugates Market, 2015-2025 (USD Million)
  4. CHAPTER 4. Antibody Drug Conjugates market – Application Analysis
    1. 4.1. Global Antibody Drug Conjugates Market – Application Overview
    2. 4.2. Global Antibody Drug Conjugates Market Share, by Application, 2018 & 2025 (USD Million)
    3. 4.3. Breast Cancer
      1. 4.3.1. Global Breast Cancer Antibody Drug Conjugates Market, 2015-2025 (USD Million)
    4. 4.4. Lymphoma
      1. 4.4.1. Global Lymphoma Antibody Drug Conjugates Market, 2015-2025 (USD Million)
  5. CHAPTER 5. Antibody Drug Conjugates market – Regional Analysis
    1. 5.1. Global Antibody Drug Conjugates Market Regional Overview
    2. 5.2. Global Antibody Drug Conjugates Market Share, by Region, 2018 & 2025 (Value)
    3. 5.3. North America
      1. 5.3.1. North America Antibody Drug Conjugates Market size and forecast, 2015-2025
      2. 5.3.2. North America Antibody Drug Conjugates Market, by Country, 2018 & 2025 (USD Million)
      3. 5.3.3. North America Antibody Drug Conjugates Market, by Drugs, 2015-2025
      4. 5.3.4. North America Antibody Drug Conjugates Market, by Mechanism of Action, 2015-2025
      5. 5.3.5. North America Antibody Drug Conjugates Market, by Application, 2015-2025
      6. 5.3.6. U.S.
      7. 5.3.7. Canada
    4. 5.4. Europe
      1. 5.4.1. Europe Antibody Drug Conjugates Market size and forecast, 2015-2025
      2. 5.4.2. Europe Antibody Drug Conjugates Market, by Country, 2018 & 2025 (USD Million)
      3. 5.4.3. Europe Antibody Drug Conjugates Market, by Drugs, 2015-2025
      4. 5.4.4. Europe Antibody Drug Conjugates Market, by Mechanism of Action, 2015-2025
      5. 5.4.5. Europe Antibody Drug Conjugates Market, by Application, 2015-2025
      6. 5.4.6. Germany
      7. 5.4.7. France
      8. 5.4.8. U.K.
      9. 5.4.9. Italy
      10. 5.4.10. Spain
      11. 5.4.11. Rest of Europe
    5. 5.5. Asia Pacific
      1. 5.5.1. Asia Pacific Antibody Drug Conjugates Market size and forecast, 2015-2025
      2. 5.5.2. Asia Pacific Antibody Drug Conjugates Market, by Country, 2018 & 2025 (USD Million)
      3. 5.5.3. Asia Pacific Antibody Drug Conjugates Market, by Drugs, 2015-2025
      4. 5.5.4. Asia Pacific Antibody Drug Conjugates Market, by Mechanism of Action, 2015-2025
      5. 5.5.5. Asia Pacific Antibody Drug Conjugates Market, by Application, 2015-2025
      6. 5.5.6. China
      7. 5.5.7. Japan
      8. 5.5.8. India
      9. 5.5.9. South Korea
      10. 5.5.10. South-East Asia
      11. 5.5.11. Rest of Asia Pacific
    6. 5.6. Latin America
      1. 5.6.1. Latin America Antibody Drug Conjugates Market size and forecast, 2015-2025
      2. 5.6.2. Latin America Antibody Drug Conjugates Market, by Country, 2018 & 2025 (USD Million)
      3. 5.6.3. Latin America Antibody Drug Conjugates Market, by Drugs, 2015-2025
      4. 5.6.4. Latin America Antibody Drug Conjugates Market, by Mechanism of Action, 2015-2025
      5. 5.6.5. Latin America Antibody Drug Conjugates Market, by Application, 2015-2025
      6. 5.6.6. Brazil
      7. 5.6.7. Mexico
      8. 5.6.8. Rest of Latin America
    7. 5.7. The Middle-East and Africa
      1. 5.7.1. The Middle-East and Africa Antibody Drug Conjugates Market size and forecast, 2015-2025
      2. 5.7.2. The Middle-East and Africa Antibody Drug Conjugates Market, by Country, 2018 & 2025 (USD Million)
      3. 5.7.3. The Middle-East and Africa Antibody Drug Conjugates Market, by Drugs, 2015-2025
      4. 5.7.4. The Middle-East and Africa Antibody Drug Conjugates Market, by Mechanism of Action, 2015-2025
      5. 5.7.5. The Middle-East and Africa Antibody Drug Conjugates Market, by Application, 2015-2025
      6. 5.7.6. GCC Countries
      7. 5.7.7. South Africa
      8. 5.7.8. Rest of Middle-East Africa
  6. CHAPTER 6. Antibody Drug Conjugates market – Competitive Landscape
    1. 6.1. Competitor Market Share – Revenue
    2. 6.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
    3. 6.3. Strategic Development
      1. 6.3.1. Acquisitions and Mergers
      2. 6.3.2. New Products
      3. 6.3.3. Research & Development Activities
  7. CHAPTER 7. Company Profiles
    1. 7.1. PFIZER, INC.
      1. 7.1.1. Company Overview
      2. 7.1.2. PFIZER, INC. Revenue and Gross Margin
      3. 7.1.3. Product portfolio
      4. 7.1.4. Recent initiatives
    2. 7.2. CELLDEX THERAPEUTICS INC.
      1. 7.2.1. Company Overview
      2. 7.2.2. CELLDEX THERAPEUTICS INC. Revenue and Gross Margin
      3. 7.2.3. Product portfolio
      4. 7.2.4. Recent initiatives
    3. 7.3. SEATTLE GENETICS INC.
      1. 7.3.1. Company Overview
      2. 7.3.2. SEATTLE GENETICS INC. Revenue and Gross Margin
      3. 7.3.3. Product portfolio
      4. 7.3.4. Recent initiatives
    4. 7.4. GENENTECH INC.
      1. 7.4.1. Company Overview
      2. 7.4.2. GENENTECH INC. Revenue and Gross Margin
      3. 7.4.3. Product portfolio
      4. 7.4.4. Recent initiatives
    5. 7.5. IMMUNOGEN INC.
      1. 7.5.1. Company Overview
      2. 7.5.2. IMMUNOGEN INC. Revenue and Gross Margin
      3. 7.5.3. Product portfolio
      4. 7.5.4. Recent initiatives
    6. 7.6. SANOFI S.A.
      1. 7.6.1. Company Overview
      2. 7.6.2. SANOFI S.A. Revenue and Gross Margin
      3. 7.6.3. Product portfolio
      4. 7.6.4. Recent initiatives
    7. 7.7. IMMUNOMEDICS, INC.
      1. 7.7.1. Company Overview
      2. 7.7.2. IMMUNOMEDICS, INC. Revenue and Gross Margin
      3. 7.7.3. Product portfolio
      4. 7.7.4. Recent initiatives
    8. 7.8. PROGENICS PHARMACEUTICALS INC.
      1. 7.8.1. Company Overview
      2. 7.8.2. PROGENICS PHARMACEUTICALS INC. Revenue and Gross Margin
      3. 7.8.3. Product portfolio
      4. 7.8.4. Recent initiatives
    9. 7.9. BAYER HEALTHCARE PHARMACEUTICALS
      1. 7.9.1. Company Overview
      2. 7.9.2. BAYER HEALTHCARE PHARMACEUTICALS Revenue and Gross Margin
      3. 7.9.3. Product portfolio
      4. 7.9.4. Recent initiatives
    10. 7.10. SYNTHON HOLDING B.V.
      1. 7.10.1. Company Overview
      2. 7.10.2. SYNTHON HOLDING B.V. Revenue and Gross Margin
      3. 7.10.3. Product portfolio
      4. 7.10.4. Recent initiatives
  8. CHAPTER 8. Antibody Drug Conjugates — Industry Analysis
    1. 8.1. Antibody Drug Conjugates Market – Key Trends
      1. 8.1.1. Market Drivers
      2. 8.1.2. Market Restraints
      3. 8.1.3. Market Opportunities
    2. 8.2. Value Chain Analysis
    3. 8.3. Technology Roadmap and Timeline
    4. 8.4. Antibody Drug Conjugates Market – Attractiveness Analysis
      1. 8.4.1. By Drugs
      2. 8.4.2. By Mechanism of Action
      3. 8.4.3. By Application
      4. 8.4.4. By Region
  9. CHAPTER 9. Marketing Strategy Analysis, Distributors
    1. 9.1. Marketing Channel
    2. 9.2. Direct Marketing
    3. 9.3. Indirect Marketing
    4. 9.4. Marketing Channel Development Trend
    5. 9.5. Economic/Political Environmental Change
  10. CHAPTER 10. Report Conclusion
  11. CHAPTER 11. Research Approach & Methodology
    1. 11.1. Report Description
    2. 11.2. Research Scope
    3. 11.3. Research Methodology
      1. 11.3.1. Secondary Research
      2. 11.3.2. Primary Research
      3. 11.3.3. Models
  •  

    List of Figures

    FIG. 1 Global Antibody Drug Conjugates Market, 2015-2025 (USD Million)
    FIG. 2 Global Antibody Drug Conjugates Market Share, by Drugs, 2018 & 2025 (USD Million)
    FIG. 3 Global Adcetris Antibody Drug Conjugates Market, 2015-2025 (USD Million)
    FIG. 4 Global Kadcyla Antibody Drug Conjugates Market, 2015-2025 (USD Million)
    FIG. 5 Global Antibody Drug Conjugates Market Share, by Mechanism of Action, 2018 & 2025 (USD Million)
    FIG. 6 Global CD30 Antibodies Antibody Drug Conjugates Market, 2015-2025 (USD Million)
    FIG. 7 Global HER2 Antibodies Antibody Drug Conjugates Market, 2015-2025 (USD Million)
    FIG. 8 Global Antibody Drug Conjugates Market Share, by Application, 2018 & 2025 (USD Million)
    FIG. 9 Global Breast Cancer Antibody Drug Conjugates Market, 2015-2025 (USD Million)
    FIG. 10 Global Lymphoma Antibody Drug Conjugates Market, 2015-2025 (USD Million)
    FIG. 11 Global Antibody Drug Conjugates Market Share, by Region, 2018 & 2025
    FIG. 12 North America Antibody Drug Conjugates Market, 2015-2025
    FIG. 13 U.S. Antibody Drug Conjugates Market, 2015-2025
    FIG. 14 Canada Antibody Drug Conjugates Market, 2015-2025
    FIG. 15 Europe Antibody Drug Conjugates Market, 2015-2025
    FIG. 16 Germany Antibody Drug Conjugates Market, 2015-2025
    FIG. 17 France Antibody Drug Conjugates Market, 2015-2025
    FIG. 18 U.K. Antibody Drug Conjugates Market, 2015-2025
    FIG. 19 Italy Antibody Drug Conjugates Market, 2015-2025
    FIG. 20 Spain Antibody Drug Conjugates Market, 2015-2025
    FIG. 21 Rest of Europe Antibody Drug Conjugates Market, 2015-2025
    FIG. 22 Asia Pacific Antibody Drug Conjugates Market, 2015-2025
    FIG. 23 China Antibody Drug Conjugates Market, 2015-2025
    FIG. 24 Japan Antibody Drug Conjugates Market, 2015-2025
    FIG. 25 India Antibody Drug Conjugates Market, 2015-2025
    FIG. 26 South  Korea Antibody Drug Conjugates Market, 2015-2025
    FIG. 27 South-East Asia Antibody Drug Conjugates Market, 2015-2025
    FIG. 28 Rest of Asia Pacific Antibody Drug Conjugates Market, 2015-2025
    FIG. 29 Latin America Antibody Drug Conjugates Market, 2015-2025
    FIG. 30 Brazil Antibody Drug Conjugates Market, 2015-2025
    FIG. 31 Mexico Antibody Drug Conjugates Market, 2015-2025
    FIG. 32 Rest of Latin America Antibody Drug Conjugates Market, 2015-2025
    FIG. 33 The Middle-East and Africa Antibody Drug Conjugates Market, 2015-2025
    FIG. 34 GCC Countries Antibody Drug Conjugates Market, 2015-2025
    FIG. 35 South Africa Antibody Drug Conjugates Market, 2015-2025
    FIG. 36 Rest of Middle-East Africa Antibody Drug Conjugates Market, 2015-2025
    FIG. 37 Competitor Market Share – Revenue
    FIG. 38 PFIZER, INC. Revenue and Growth Rate
    FIG. 39 PFIZER, INC. Market Share
    FIG. 40 CELLDEX THERAPEUTICS INC. Revenue and Growth Rate
    FIG. 41 CELLDEX THERAPEUTICS INC. Market Share
    FIG. 42 SEATTLE GENETICS INC. Revenue and Growth Rate
    FIG. 43 SEATTLE GENETICS INC. Market Share
    FIG. 44 GENENTECH INC. Revenue and Growth Rate
    FIG. 45 GENENTECH INC. Market Share
    FIG. 46 IMMUNOGEN INC. Revenue and Growth Rate
    FIG. 47 IMMUNOGEN INC. Market Share
    FIG. 48 SANOFI S.A. Revenue and Growth Rate
    FIG. 49 SANOFI S.A. Market Share
    FIG. 50 IMMUNOMEDICS, INC. Revenue and Growth Rate
    FIG. 51 IMMUNOMEDICS, INC. Market Share
    FIG. 52 PROGENICS PHARMACEUTICALS INC. Revenue and Growth Rate
    FIG. 53 PROGENICS PHARMACEUTICALS INC. Market Share
    FIG. 54 BAYER HEALTHCARE PHARMACEUTICALS Revenue and Growth Rate
    FIG. 55 BAYER HEALTHCARE PHARMACEUTICALS Market Share
    FIG. 56 SYNTHON HOLDING B.V. Revenue and Growth Rate
    FIG. 57 SYNTHON HOLDING B.V. Market Share
    FIG. 58 Market Dynamics
    FIG. 59 Global Antibody Drug Conjugates – Value Chain Analysis
    FIG. 60 Technology Roadmap and Timeline
    FIG. 61 Market Attractiveness Analysis – By Drugs
    FIG. 62 Market Attractiveness Analysis – By Mechanism of Action
    FIG. 63 Market Attractiveness Analysis – By Application
    FIG. 64 Market Attractiveness Analysis – By Region
    FIG. 65 Market Channel
    FIG. 66 Marketing Channel Development Trend
    FIG. 67 Growth in World Gross Product, 2008-2018


    List of Tables

    TABLE 1 Global Antibody Drug Conjugates Market, 2018 & 2025 (USD Million)
    TABLE 2 Global Antibody Drug Conjugates market, by Drugs, 2015-2025 (USD Million)
    TABLE 3 Global Antibody Drug Conjugates market, by Mechanism of Action, 2015-2025 (USD Million)
    TABLE 4 Global Antibody Drug Conjugates market, by Application, 2015-2025 (USD Million)
    TABLE 5 Global Antibody Drug Conjugates market, by Region, 2015-2025 (USD Million)
    TABLE 6 North America Antibody Drug Conjugates Market, by Drugs, 2015-2025 (USD Million)
    TABLE 7 North America Antibody Drug Conjugates Market, by Mechanism of Action, 2015-2025 (USD Million)
    TABLE 8 North America Antibody Drug Conjugates Market, by Application, 2015-2025 (USD Million)
    TABLE 9 Europe Antibody Drug Conjugates Market, by Drugs, 2015-2025 (USD Million)
    TABLE 10 Europe Antibody Drug Conjugates Market, by Mechanism of Action, 2015-2025 (USD Million)
    TABLE 11 Europe Antibody Drug Conjugates Market, by Application, 2015-2025 (USD Million)
    TABLE 12 Asia Pacific Antibody Drug Conjugates Market, by Drugs, 2015-2025 (USD Million)
    TABLE 13 Asia Pacific Antibody Drug Conjugates Market, by Mechanism of Action, 2015-2025 (USD Million)
    TABLE 14 Asia Pacific Antibody Drug Conjugates Market, by Application, 2015-2025 (USD Million)
    TABLE 15 Latin America Antibody Drug Conjugates Market, by Drugs, 2015-2025 (USD Million)
    TABLE 16 Latin America Antibody Drug Conjugates Market, by Mechanism of Action, 2015-2025 (USD Million)
    TABLE 17 Latin America Antibody Drug Conjugates Market, by Application, 2015-2025 (USD Million)
    TABLE 18 The Middle-East and Africa Antibody Drug Conjugates Market, by Drugs, 2015-2025 (USD Million)
    TABLE 19 The Middle-East and Africa Antibody Drug Conjugates Market, by Mechanism of Action, 2015-2025 (USD Million)
    TABLE 20 The Middle-East and Africa Antibody Drug Conjugates Market, by Application, 2015-2025 (USD Million)
    TABLE 21 Global Antibody Drug Conjugates Market - Company Revenue Analysis 2015-2018 (USD Million)
    TABLE 22 Global Antibody Drug Conjugates Market - Company Revenue Share Analysis 2015-2018(%)
    TABLE 23 Acquisitions and Mergers
    TABLE 24 New Product/Service Launch
    TABLE 25 Research & Development Activities
    TABLE 26 Market Drivers
    TABLE 27 Market Restraints
    TABLE 28 Market Opportunities

  • Industry Major Market Players

    • Synthon Holding B.V.
    •  Seattle Genetics Inc.
    •  Sanofi S.A.
    •  Progenics Pharmaceuticals Inc.
    •  Pfizer Inc.
    •  Immunomedics Inc.
    •  Immunogen Inc.
    •  Genentech Inc.
    •  Celldex Therapeutics Inc.
    •   Bayer Healthcare Pharmaceuticals

    Latest Added Market Report

    Surface Disinfectant Market By Composition (Alcohols, Chlorine Compounds, Quaternary Ammonium Compounds, Hydrogen Peroxide, Peracetic Acid, and Other Compositions), By Type (Liquids, Wipes, and Sprays), By Application (Surface Disinfection, Instrument Disinfection, and Other Applications), By End-User (Hospital Settings, Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, and Research Laboratories): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026

    This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the surface disinfectant industry. The report analyzes and declares the historical and current trends analysis of the surface disinfectant industry and subsequently recommends the projected trends anticipated to be observed in the surface disinfectant market during the upcoming years. The ...

    Published Date : 18-Sep-2020 | | Category : Healthcare | Pages : 220 | Format : Read more

    Plastic Medical Face Shield Market By Type (Full Face Shield and Half Face Shield) By Material (Polycarbonate, Propionate, Acetate, Polyvinyl Chloride, Polyethylene Terephthalate Glycol (PETG), Others) By Application (Hospitals, Clinics, Medical Shops, Others): Global Plastic Medical Face Shield Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026

    This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the Plastic Medical Face Shield industry. The report analyzes and declares the historical and current trends analysis of the Plastic Medical Face Shield industry and subsequently recommends the projected trends anticipated to be observed in the Plastic Medical Face Shield market during the upcoming years. The <a href="https://www.fnfresearch.com/news/plastic- ...

    Published Date : 18-Sep-2020 | | Category : Chemical & Materials | Pages : 190 | Format : Read more

    Europe Sofa and Chair Market By Sofa Type (Leather Sofa, Fabric Sofa, Wood Sofa, Others) By Chair Type (Backrest Chair, Multifunctional Chair, Folding Chair, Lounge Chair, Arm Chair, Others) By Material (Fabric, Leather, Others) By Style (Modern, Classic) By Usage (Private Home, Office Usage, Indoor, Outdoor) By Application (Household, Commercial): Europe Sofa and Chair Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026

    This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the Europe Sofa and Chair industry. The report analyzes and declares the historical and current trends analysis of the Europe Sofa and Chair industry and subsequently recommends the projected trends anticipated to be observed in the Europe Sofa and Chair market during the upcoming years. The <a href="https://www.fnfresearch.com/news/europe-sofa-and-chair-mark ...

    Published Date : 18-Sep-2020 | | Category : Consumer Goods | Pages : 188 | Format : Read more

    Safe and Secure SSL Encrypted

    Choose License Type

    Inquiry For Buying

    COVID-19 Pandemic Impacts

    Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

    have a question

    HAVE A QUESTION? Executive will help you find what you are looking for.


    REQUEST CUSTOMIZATION

    Still haven't found what you're looking for? Speak to our Custom Research Team

    Learn More
    Facts & Factors provides an array of marketing and business research solutions distinctly designed by our expertise for the clients.
    Copyright © 2020 Facts & Factors. All Rights Reserved. Sitemap - Privacy Policy - Terms & Conditions